Online Trial Tracker - Larvol Sigma

Senl_22 / Avalon GloboCare

Welcome, Profile Billing Logout

1 Trials

All TrialsPhase N/A

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Senl_22 / SenlangBio

NCT04546906: Safety and Efficacy Study of CD22 CAR-T Cells for Relapsed or Refractory Acute Lymphoblastic Leukemia

Recruiting

N/A

RoW

CD22 CAR-T

Hebei Senlang Biotechnology Inc., Ltd.

B-ALL

09/22

12/22

Download Options



	Diseases Companies Products Productz Mechanisms of Action Sites